- Moscicki A-B, Hills N, Shiboski S, y cols. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA. 2001;285:2995–3002.
- World Health Organization, Department of Vaccines and Other Biologicals, and International Agency for Research on Cancer. The current status of development of prophylactic vaccines against human papillomavirus infection: Report of a technical meeting, Geneva, 16–18 February 1999. Génova, Suiza: Organización Mundial de la Salud: 1999.
- Hatch KD, Berek JS. Intraepithelial disease of the cervix, vagina, and vulva. En: Berkek JS, ed. Novak's Gynecology. 13ª edición; 2002:471–505.
- Minucci D, Cinel A, Insacco E, Oselladore M. Epidemiological aspects of vaginal intraepithelial neoplasis (VAIN). Clin Exp Obstet Gynecol. 1995;22:36–42.
- Maw RD, Reitano M, Roy M. An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle. Int J STD AIDS. 1998;9:571–578.
- World Health Organization. Sexually transmitted infections increasing—250 million new infections annually. WHO Features [comunicado de prensa]. Diciembre 1990;No.152:1–6.
- Abramson AL, Nouri M, Mullooly V, Fisch G, Steinberg BM. Latent human papillomavirus infection is comparable in the larynx and traches. J Med Virol. 2004;72:473–477.
- Derkay CS. Task force on recurrent respiratory papillomas: A preliminary report. Arch Otalaryngol Head Neck Surg. 1995;121:1386–1391.
Lea nuestra